SEHA’s Corniche Fertility Centre has successfully completed a fertility preservation programme for a 30-year-old patient with recurrent ovarian cancer, allowing her to preserve future family-building options without delaying chemotherapy.

Following a diagnosis of recurrent juvenile granulosa cell tumour of the ovary, the patient was urgently referred to the fertility centre because of the potential impact of cancer treatment on reproductive health. Her initial consultation took place within a week, with ovarian stimulation beginning the following day.

As the patient was married, the medical team recommended embryo cryopreservation. Eggs were retrieved from the remaining ovary, fertilised and developed into five embryos, which were successfully frozen for potential future use. The fertility preservation process was completed within the required clinical window, allowing the patient to begin chemotherapy as scheduled.

Click here to join our WhatsApp channel here

Dr. Arianna D’Angelo, consultant Physician at SEHA’s Corniche Fertility Centre, said: “A cancer diagnosis understandably shifts immediate focus to life-saving treatment. However, concerns about future fertility are equally significant for many patients. Early referral and close coordination between oncology and reproductive medicine teams allow us to provide effective fertility preservation without compromising cancer care timelines.”

Fertility preservation options can include freezing eggs, sperm or embryos, depending on the patient’s circumstances. Early discussions following a cancer diagnosis can help patients make informed decisions before treatment begins.

Also read: PMFG Summit 2026 to Explore Advances in Genomic Medicine and AI